591 related articles for article (PubMed ID: 18333841)
1. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
Franchini M; Montagnana M; Lippi G
Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
[TBL] [Abstract][Full Text] [Related]
2. Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes.
Othman M
Semin Thromb Hemost; 2007 Nov; 33(8):780-6. PubMed ID: 18175283
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
Favaloro EJ
Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance.
Enayat MS; Guilliatt AM; Lester W; Wilde JT; Williams MD; Hill FG
Br J Haematol; 2006 Jun; 133(6):664-6. PubMed ID: 16704444
[TBL] [Abstract][Full Text] [Related]
5. [Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases].
Guermazi S; Conard J; Samama MM; Dellagi K
Pathol Biol (Paris); 2006 Apr; 54(3):159-65. PubMed ID: 16176858
[TBL] [Abstract][Full Text] [Related]
6. Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder.
Othman M
Semin Thromb Hemost; 2011 Jul; 37(5):464-9. PubMed ID: 22102188
[TBL] [Abstract][Full Text] [Related]
7. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
8. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
9. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis.
Favaloro EJ; Patterson D; Denholm A; Mead S; Gilbert A; Collins A; Estell J; George PM; Smith MP
Br J Haematol; 2007 Nov; 139(4):623-6. PubMed ID: 17916098
[No Abstract] [Full Text] [Related]
10. 2B or not 2B? Differential identification of Type 2B, versus pseudo-,von Willebrand disease.
Whalley IN; Perry DJ
Br J Haematol; 2007 Jan; 136(2):345; author reply 345-6. PubMed ID: 17233824
[No Abstract] [Full Text] [Related]
11. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
[TBL] [Abstract][Full Text] [Related]
12. Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma.
Takimoto Y; Imanaka F
Int J Hematol; 1999 Aug; 70(2):127-31. PubMed ID: 10497852
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
14. [Information on von Willebrand disease].
Nishino M; Fujimura Y
Rinsho Byori; 1997 Oct; 45(10):942-50. PubMed ID: 9369071
[TBL] [Abstract][Full Text] [Related]
15. Management of inherited von Willebrand disease in 2007.
Federici AB; Mannucci PM
Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of inherited von Willebrand disease: a clinical perspective.
Federici AB
Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
[TBL] [Abstract][Full Text] [Related]
17. A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease.
Enayat S; Ravanbod S; Rassoulzadegan M; Jazebi M; Tarighat S; Ala F; Emsley J; Othman M
Thromb Haemost; 2012 Nov; 108(5):946-54. PubMed ID: 23014764
[TBL] [Abstract][Full Text] [Related]
18. Biomedicine. Contact--how platelets touch von Willebrand factor.
Sadler JE
Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
[No Abstract] [Full Text] [Related]
19. [Acquired von Willebrand syndrome].
Franchini M
Recenti Prog Med; 2006; 97(7-8):417-21; quiz 440. PubMed ID: 16913181
[TBL] [Abstract][Full Text] [Related]
20. The problem of diagnosing von Willebrand's disease.
Batlle J; Torea J; Rendal E; Fernández MF
J Intern Med Suppl; 1997; 740():121-8. PubMed ID: 9350193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]